Noam Solomon and Luis Voloch (Immunai)
Wading deeper into target discovery and validation, Immunai bags $60M to beef up both AI algorithms and lab benches
Noam Solomon and Luis Voloch set out, when they launched Immunai in 2018, to map out the immune system cell by cell.
The two engineers …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.